Can I Take Glycine with Prometrium?

What Prometrium Is and How It Works

Prometrium is the brand-name oral formulation of micronized progesterone suspended in peanut oil. The FDA approved it for two main indications: endometrial protection in postmenopausal women using conjugated estrogens, and secondary amenorrhea. At the 200 mg dose taken for 12 consecutive days per cycle, PEPI trial data showed it produced a significantly better endometrial-safety profile than medroxyprogesterone acetate while preserving HDL-cholesterol benefits of estrogen therapy. [1]

Absorption and Metabolism

Oral micronized progesterone is absorbed through the gastrointestinal tract and undergoes extensive first-pass hepatic metabolism via cytochrome P450 enzymes, primarily CYP3A4. Peak plasma concentration (Cmax) occurs roughly 3 hours after ingestion. Bioavailability is low and variable, approximately 10 percent, which is why taking Prometrium with food increases absorption by up to 3-fold. [2]

Neurosteroid Activity Explains the Sedative Effect

Progesterone is converted in both liver and brain tissue to allopregnanolone (3-alpha, 5-alpha-tetrahydroprogesterone), a potent positive allosteric modulator of GABA-A receptors. This conversion explains the well-documented sedative and anxiolytic effects of oral Prometrium that are not seen to the same degree with vaginal progesterone or synthetic progestins. A 2018 review in Menopause noted that allopregnanolone levels correlate directly with subjective sleepiness reported by Prometrium users. [3]

What Glycine Does in the Body

Glycine is the simplest amino acid, present in every human cell and conditionally essential in high physiological-demand states. Adults synthesize roughly 3 g per day endogenously, but demand may exceed 10 g per day during tissue repair or metabolic stress. [4] Dietary sources include collagen-rich foods: bone broth, skin-on poultry, and gelatin.

Sleep Mechanism

A randomized, double-blind crossover trial published in Sleep and Biological Rhythms (N=11) found that 3 g of glycine taken before bed reduced fatigue and improved daytime sleepiness scores compared with placebo, with polysomnography confirming faster sleep onset and increased slow-wave sleep time. [5] The proposed mechanism involves glycine-mediated hypothalamic cooling via peripheral vasodilation rather than direct CNS sedation. This is a meaningful distinction: glycine's sleep promotion operates through a thermogenic pathway while Prometrium's operates through GABA-A potentiation.

Glycemic Effects

Glycine is a co-agonist at the NMDA receptor and also stimulates glucagon-like peptide-1 (GLP-1) release from intestinal L-cells. A 2015 metabolomics study in Diabetes Care (N=2,422 participants across multiple cohorts) found that higher fasting plasma glycine concentrations were independently associated with lower type 2 diabetes risk and better insulin sensitivity. [6] Supplemental glycine at 5 g three times daily modestly reduced fasting glucose in a 3-month pilot trial in people with metabolic syndrome. [7]

Collagen Synthesis and Other Roles

Glycine makes up roughly 33 percent of the amino acid composition of collagen. Oral collagen peptide supplementation (which liberates glycine during digestion) has been studied for skin, joint, and bone outcomes, though those data are outside the direct scope of this article.

Pharmacokinetic Interaction: Is There One?

The short answer is no well-documented pharmacokinetic interaction exists. Prometrium is metabolized primarily by CYP3A4, with minor contributions from CYP2C19. Glycine is not a substrate, inducer, or inhibitor of any major cytochrome P450 enzyme. [8] It is absorbed via sodium-coupled neutral amino acid transporters (SNAT1 and SNAT2) in the gut, distributed freely in plasma, and catabolized through the glycine cleavage system in mitochondria.

There is no plausible mechanistic pathway by which supplemental glycine would alter Prometrium's absorption rate, peak concentration, or elimination half-life. No pharmacokinetic interaction studies specifically examining this pair have been registered on ClinicalTrials.gov as of mid-2025.

Protein Binding: A Non-Issue

Progesterone circulates approximately 96 to 99 percent bound to albumin and sex hormone-binding globulin. Glycine does not compete meaningfully for albumin binding sites, and displacement interactions at that level of binding are typically clinically insignificant unless the displacing molecule has very high affinity and narrow-therapeutic-index constraints. Prometrium's wide therapeutic index makes even theoretical displacement irrelevant. [9]

Pharmacodynamic Interaction: Additive Sedation

This is the clinically relevant consideration. Both Prometrium and glycine independently promote sleep and reduce core body temperature before sleep onset. Their mechanisms do not overlap at the receptor level, which means the effects add together without amplifying each other exponentially. The correct term is additive pharmacodynamic interaction, not synergistic.

What Additive Sedation Looks Like in Practice

A 52-year-old woman taking Prometrium 200 mg at bedtime during the luteal phase of a cycling HRT regimen may already notice morning grogginess for the first few nights after starting the medication. Adding 3 g of glycine on top could extend that grogginess window by 30 to 60 minutes in sensitive individuals. This is not dangerous for most people but may matter for those who drive early in the morning or operate machinery.

Risk Stratification

Women using Prometrium at the lower continuous dose of 100 mg nightly carry less sedation burden and are likely to tolerate 3 g of glycine without meaningful functional impairment. Those on the 200 mg cyclic protocol or who already experience notable Prometrium sedation should start glycine at 1 to 2 g rather than the standard 3 g dose and titrate over 2 weeks.

Glycine's Glycemic Effect in the Context of Progesterone's Metabolic Profile

Progesterone and synthetic progestins differ substantially in their metabolic effects. Micronized progesterone has a more neutral impact on insulin sensitivity compared with medroxyprogesterone acetate. The KEEPS trial (Kronos Early Estrogen Prevention Study, N=727) found that oral micronized progesterone did not significantly worsen fasting glucose or insulin resistance markers over 48 months of use. [10]

Glycine's mild glucose-lowering effect at supplemental doses (5 g three times daily) is unlikely to cause clinically significant hypoglycemia in healthy women. However, in women who are also using insulin, sulfonylureas, or GLP-1 receptor agonists alongside their HRT, the additive glycemic effect warrants monitoring.

Blood glucose below 70 mg/dL while symptomatic (sweating, tremor, confusion) requires prompt clinical evaluation regardless of supplement status.

Does Glycine Affect Progesterone Levels Directly?

No published human data demonstrate that glycine supplementation alters serum progesterone concentrations. Glycine is not a precursor in the steroidogenesis pathway. Cholesterol, through a series of enzymatic steps beginning with StAR protein transport into the mitochondria and CYP11A1 (cholesterol side-chain cleavage enzyme), is the rate-limiting precursor to progesterone. Glycine sits outside this pathway entirely. [11]

HealthRX Clinical Decision Framework: Glycine + Prometrium

| Clinical Profile | Prometrium Dose | Recommended Starting Glycine Dose | Extra Monitoring | |---|---|---|---| | Healthy postmenopausal, no diabetes | 100 mg nightly | 3 g at bedtime | Subjective morning sedation only | | Healthy postmenopausal, no diabetes | 200 mg cyclic (12 days) | 1 to 2 g at bedtime; titrate up | Morning sedation; delay driving 8 hours | | Type 2 diabetes or prediabetes, on oral agent | 100 mg or 200 mg | 1 g at bedtime; discuss with provider | Fasting glucose weekly for 4 weeks | | On insulin or GLP-1 agonist | Any | Defer to prescribing provider | Fingerstick BG before bed and on waking | | Significant insomnia already treated pharmacologically | Any | Discuss with provider first | Avoid stacking additional sedating agents |

Timing: Should You Separate the Doses?

Because the interaction is pharmacodynamic rather than pharmacokinetic, strict dose separation is not required to prevent a chemical reaction or absorption block. Both agents are commonly taken at bedtime, and that timing is actually convenient for their shared sleep-promoting properties.

Taking Prometrium with a small fatty snack (as the prescribing information recommends) does not meaningfully interfere with glycine absorption, which is rapid and transporter-mediated.

If sedation is a concern, one practical strategy is to shift glycine to 30 minutes before bed while taking Prometrium immediately at bedtime with food. The 30-minute offset does not eliminate additive sedation but may slightly blunt the peak overlap of both compounds' activity windows.

Collagen Synthesis and Skin Health on HRT: A Relevant Note

Postmenopausal estrogen loss reduces dermal collagen content by approximately 30 percent in the first 5 years after menopause, with a subsequent decline of 2.1 percent per year thereafter. [12] Glycine's role in collagen synthesis makes it a popular add-on for women on HRT who are managing skin and joint changes.

Prometrium does not appear to inhibit collagen synthesis. Some preclinical data suggest progesterone receptors in dermal fibroblasts may have a supportive role in extracellular matrix maintenance, though strong human clinical trial data on this specific question are limited. Glycine supplementation alongside Prometrium for skin or joint goals carries no known antagonism and may provide complementary benefit.

Monitoring Checklist for Women Taking Both

First 2 Weeks

Check in with yourself each morning. Note whether grogginess extends past 60 minutes after waking. If it does, reduce glycine dose by half.

If you have diabetes or prediabetes, log fasting blood glucose daily for the first 14 days after adding glycine. Bring those logs to your next provider visit.

Ongoing

After 4 weeks of stable combined use, monitoring reduces to standard HRT follow-up: an annual review including blood pressure, fasting metabolic panel, and symptom review. No specific glycine-related laboratory test is needed in healthy individuals without glycine metabolism disorders (such as non-ketotic hyperglycinemia, which is a rare congenital condition unrelated to supplementation).

When to Stop Glycine and Contact Your Provider

Stop glycine and contact your prescribing clinician if you experience:

• Morning sedation lasting more than 2 hours that does not resolve after reducing glycine dose
• Fasting glucose below 70 mg/dL with symptoms
• Any new neurological symptom (confusion, vision changes, ataxia) that coincides with starting glycine

What Major Guidelines Say About Progesterone and Supplement Combinations

The 2022 Menopause Society (formerly NAMS) position statement on menopausal hormone therapy does not specifically address glycine co-administration. It does state: "Micronized progesterone is the preferred progestogen for women who have tolerability concerns, given its neutral metabolic profile and favorable sleep effects." [13] This framing is relevant because it acknowledges sleep as an intended benefit of Prometrium, making the additive sleep effect of glycine a feature to manage rather than an alarming interaction.

The Endocrine Society's 2015 Clinical Practice Guideline on menopausal hormone therapy recommends using the lowest effective dose of progestogen and notes that oral progesterone has CNS-active metabolites that require patient counseling. [14] Layering any additional sleep-promoting agent, including glycine, falls within the spirit of that counseling requirement.

Special Populations

Women With Peanut Allergy

Prometrium capsules contain peanut oil. The FDA label carries a contraindication for patients with peanut allergy. Glycine supplementation is not relevant to this contraindication. Women with peanut allergy who need progesterone should discuss compounded micronized progesterone formulations with their provider. This is a Prometrium-specific safety issue, not a glycine interaction.

Women Using Vaginal Prometrium

Vaginal administration of micronized progesterone (100 mg suppository) produces very low systemic progesterone levels due to a uterine first-pass effect that concentrates progesterone in the endometrium. Allopregnanolone levels after vaginal dosing are substantially lower than after oral dosing. [15] Women using vaginal Prometrium carry a minimal sedation burden and can use standard glycine doses (3 g at bedtime) without the additive-sedation concern that applies to oral Prometrium users.

Adolescents and Premenopausal Women

Prometrium is sometimes used off-label for luteal-phase support or in perimenopause. Glycine at 3 g is generally recognized as safe in adults. Glycine is not approved or studied for sleep use in pediatric populations, and this article's framework applies only to adult women (age 18 and older).

Summary of Evidence Quality

The confidence in "no pharmacokinetic interaction" is high, based on mechanistic pharmacology and the absence of any documented CYP3A4 activity from glycine. The confidence in "additive pharmacodynamic sedation" is moderate, based on the independent sedation evidence for each compound rather than a head-to-head combination trial. The glycemic overlap carries low-to-moderate concern, supported by glycine's mechanism (GLP-1 stimulation) and Prometrium's neutral metabolic profile.

A well-designed randomized crossover trial examining Prometrium 200 mg plus glycine 3 g versus Prometrium alone for polysomnography outcomes in perimenopausal women would significantly improve the evidence base. No such trial was registered as of this writing.